NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
Voltar para busca
Dado oficial do USPTO
TRIALMAGNET
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TRIALMAGNET
ST13
US500000090689781Classe
9, 35, 42
Pedido
90689781
Registro
7190229
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
10/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 42
Data de depósito
04/05/2021
Data de registro
10/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/10/2023
Última transação
10/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/12/2020
Primeiro uso no comércio
14/04/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Herndon, VA, US
Examinador
NADELMAN, ANDREA KOYNER
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Jeeva Informatics Solutions, Inc.
Representantes
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software for the processing and analysis of data using artificial intelligence and natural language processing; downloadable software for planningmanagement and operational management in the field of clinical trials and long-term health management; downloadable software featuring machine learning technology for planningmanagementoperational managementstudy design optimization in the field of clinical trials and long-term health management; downloadable software for estimating the probability of clinical trial success; downloadable software featuring machine learning technology for capturingcollectingmanaginganalyzingreporting data from clinical trials and drug discovery for use in database management and processing data; downloadable software for real-time and long-term patient monitoring and safety review in the field of clinical trials
Classe 35
Business consulting and management in the field of clinical trialsproviding information management services; business consulting and management in the field of clinical trials; business consulting and management in the field of regulatory submission managementclinical trial data integrity and immutability; database management in the field of clinical trials; updating and maintenance of data in computer databases in the field of clinical trials; recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; providing independent review of clinical trials for business purposes; regulatory submission managementassisting others in preparing and filing applications for approval of new drugs and medical devices with governmental regulatory bodies
Classe 42
Software as a service (SAAS) services featuring software for the processing and analysis of data using artificial intelligence and natural language processing; Software as a service (SAAS) services featuring software for planningmanagement and operational management in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software featuring machine learning technology for planningmanagementoperational managementstudy design optimization in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software for estimating the probability of clinical trial success; Software as a service (SAAS) services featuring software featuring machine learning technology for capturingcollectingmanaginganalyzingreporting data from clinical trials and drug discovery for use in database management and processing data; scientific consulting services in the field of conducting clinical trials for others; information technology consulting services relating to the collectionreviewanalysis and reporting of clinical trialdrug developmentdrug discovery information; providing medical and scientific research information in the field of clinical trials; providing online searchable databases featuring medical and scientific research clinical trial information whereby users can input and collect data and information for research purposes; pharmaceutical research and development information services in the field of health care and clinical trials; Software as a service (SAAS) services featuring software for real-time and long-term patient monitoring and safety review in the field of clinical trials; Software as a service (SAAS) services featuring software for the processing and analysis of data for use in the discovery of disease biomarkers for diagnostic and therapeutic purposes; structural and functional analysis of genomes; database development servicesproviding configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; database development servicesproviding configuration and customization of computer databases in the field of medical information related healthcare and long-term health management; medical researchcompiling and analyzing genomics data for use in the discovery of disease biomarkers which are used for diagnostic and therapeutic purposes; conducting clinical trials for others; conducting early evaluations of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical and scientific research related to designingorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; medical researchcollectionorganizationanalysisreporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2023
ALIE
ASSIGNED TO LIE
29/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/10/2022
GNRT
NON-FINAL ACTION E-MAILED
17/10/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
17/10/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/10/2022
IUAF
USE AMENDMENT FILED
21/09/2022
EISU
TEAS STATEMENT OF USE RECEIVED
21/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/02/2022
PUBO
PUBLISHED FOR OPPOSITION
15/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/01/2022
GNRT
NON-FINAL ACTION E-MAILED
06/01/2022
CNRT
NON-FINAL ACTION WRITTEN
06/01/2022
DOCK
ASSIGNED TO EXAMINER
05/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
NWAP
NEW APPLICATION ENTERED
07/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TRIALMAGNET ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.